The anti-cancer effects of Tualang honey in modulating breast carcinogenesis: An experimental animal study

BMC Complementary and Alternative Medicine

Volumn 17, Issue 1, 2017, Pages

  Ahmed, Sarfraz ^a,b   Othman, Nor Hayati ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

Author keywords

Anti cancer effect; Apaf 1; Estrogen receptor 1; Experimental breast cancer; Honey effect on hematological parameters; Tualang honey

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 9; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HEMOGLOBIN; PROTEIN BCL XL; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOGENESIS; CANCER INCIDENCE; CANCER SIZE; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HONEY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RED BLOOD CELL DISTRIBUTION WIDTH; TUALANG HONEY; TUMOR GROWTH; ANALYSIS; ANIMAL; BREAST TUMOR; CARCINOGENESIS; DIETARY SUPPLEMENT; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOGENESIS; DIETARY SUPPLEMENTS; ESTROGENS; FEMALE; HONEY; HUMANS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN;

EID: 85018646427     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-017-1721-4     Document Type: Article

References (54)

1. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1(4):505-27.
2. Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin. 2004;54(3):150-80.
3. Raffoul JJ, Kucuk O, Sarkar FH, Hillman GG. Dietary Agents in Cancer Chemoprevention and Treatment. J Oncol. 2012;2012:2.
4. Ahmed S, Othman NH. Honey as a Potential Natural Anticancer Agent: A Review of Its Mechanisms. Evid Based Complement Alternat Med. 2013;2013:829070.
5. Nwankwo CM, Ezekoye CC, Igbokwe SO. Phytochemical screening and antimicrobial activity of apiary honey produced by honey bee (Apis mellifera) on clinical strains of Staphylococcus aureus, Escherichia coli and Candida albicans. Afr J Biotechnol. 2014;13(23):2367-72.
6. Al-Rahbi B, Zakaria R, Othman Z, Hassan A, Ahmad AH. Enhancement of BDNF Concentration and Restoration of the Hypothalamic-Pituitary-Adrenal Axis Accompany Reduced Depressive-Like Behaviour in Stressed Ovariectomised Rats Treated with Either Tualang Honey or Estrogen. Sci World J. 2014;2014:8.
7. Dagdemir A, Durif J, Ngollo M, Bignon YJ, Bernard-Gallon D. Breast cancer: mechanisms involved in action of phytoestrogens and epigenetic changes. In Vivo. 2013;27(1):1-9.
8. Ahmed S, Othman NH. Review of the medicinal effects of tualang honey and a comparison with manuka honey. Malays J Med Sci. 2013;20(3):6-13.
9. Bashkaran K, Zunaina E, Bakiah S, Sulaiman SA, Sirajudeen K, Naik V. Anti-inflammatory and antioxidant effects of Tualang honey in alkali injury on the eyes of rabbits: experimental animal study. BMC Complement Altern Med. 2011;11:90.
10. Nasir NA, Halim AS, Singh KK, Dorai AA, Haneef MN. Antibacterial properties of tualang honey and its effect in burn wound management: a comparative study. BMC Complement Altern Med. 2010;10:31.
11. Sukur SM, Halim AS, Singh KK. Evaluations of bacterial contaminated full thickness burn wound healing in Sprague Dawley rats Treated with Tualang honey. Indian J Plast Surg. 2011;44(1):112-7.
12. Tan JJ, Azmi SM, Yong YK, Cheah HL, Lim V, Sandai D, Shaharuddin B. Tualang Honey Improves Human Corneal Epithelial Progenitor Cell Migration and Cellular Resistance to Oxidative Stress In Vitro. PLoS One. 2014;9(5):e96800.
13. Erejuwa O, Sulaiman S, Wahab M, Sirajudeen K, Salleh M, Gurtu S: Hepatoprotective effect of tualang honey supplementation in streptozotocin-induced diabetic rats. 2012 2012, 4(4):5.
14. Kadir EA, Sulaiman SA, Yahya NK, Othman NH. Inhibitory effects of Tualang Honey on experimental breast cancer in rats: a preliminary study. Asian Pac J Cancer Prev. 2013;14(4):2249-54.
15. Yaacob NS, Ismail NF. Comparison of cytotoxicity and genotoxicity of 4-hydroxytamoxifen in combination with Tualang honey in MCF-7 and MCF-10A cells. BMC Complement Altern Med. 2014;14:106.
16. Ghashm AA, Othman NH, Khattak MN, Ismail NM, Saini R. Antiproliferative effect of Tualang honey on oral squamous cell carcinoma and osteosarcoma cell lines. BMC Complement Altern Med. 2010;10:49.
17. Fauzi AN, Norazmi MN, Yaacob NS. Tualang honey induces apoptosis and disrupts the mitochondrial membrane potential of human breast and cervical cancer cell lines. Food Chem Toxicol. 2011;49(4):871-8.
18. Akinbami A, Popoola A, Adediran A, Dosunmu A, Oshinaike O, Adebola P, Ajibola S. Full blood count pattern of pre-chemotherapy breast cancer patients in Lagos, Nigeria. Caspian J Intern Med. 2013;4(1):574-9.
19. Hamidullah C, Changkija B, Konwar R. Role of interleukin-10 in breast cancer. Breast Cancer Res Treat. 2012;133(1):11-21.
20. Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res. 1988;48(2):246-53.
21. Lim VW, Li J, Gong Y, Jin A, Yuan JM, Yong EL, Koh WP. Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women. Endocr Relat Cancer. 2014;21(2):263-73.
22. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 2007;87(3):905-31.
23. Portt L, Norman G, Clapp C, Greenwood M, Greenwood MT. Anti-apoptosis and cell survival: A review. Biochim Biophys Acta. 2011;1813(1):238-59.
24. Fujimoto A, Takeuchi H, Taback B, Hsueh EC, Elashoff D, Morton DL, Hoon DS. Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma. Cancer Res. 2004;64(6):2245-50.
25. Fernandez Y, Espana L, Manas S, Fabra A, Sierra A. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance. Cell Death Differ. 2000;7(4):350-9.
26. Yanniotis S, Skaltsi S, Karaburnioti S. Effect of moisture content on the viscosity of honey at different temperatures. J Food Eng. 2006;72(4):372-7.
27. Prica N, Živkov-Baloš M, Jakšić S, Mihaljev Ž, Kartalović B, Babić J, Savić S. Moisture and acidity as indicators of the quality of honey originating from Vojvodina region. Arhiv Veterinarske Medicine. 2014;7(2):99-109.
28. Thompson HJ, Adlakha H. Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-1-nitrosourea. Cancer Res. 1991;51(13):3411-5.
29. Tran-Thanh D, Buttars S, Wen Y, Wilson C, Done SJ. Cyclooxygenase-2 inhibition for the prophylaxis and treatment of preinvasive breast cancer in a her-2/neu mouse model. Cancer Prev Res (Phila). 2010;3(2):202-11.
30. Mukhopadhyay S, Ballard BR, Mukherjee S, Kabir SM, Das SK. Beneficial effects of soy protein in the initiation and progression against dimethylbenz [a] anthracene-induced breast tumors in female rats. Mol Cell Biochem. 2006;290(1-2):169-76.
31. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11(2):155-68.
32. Vivien V Ng et al.: Clinical Review: Breast cancer. Cancer Research UK http://www.gponline.com/clinical-review-breast-cancer/cancer/womens/article/1316469 2014.
33. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R, Sigman CC. Chemopreventive drug development: perspectives and progress. Cancer Epidemiol Biomark Prev. 1994;3(1):85-98.
34. Wang XH, Andrae L, Engeseth NJ. Antimutagenic effect of various honeys and sugars against Trp-p-1. J Agric Food Chem. 2002;50(23):6923-8.
35. Barrett JC. Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect. 1993;100:9-20.
36. Rozados VR, Sanchez AM, Gervasoni SI, Berra HH, Matar P, Graciela Scharovsky O. Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity. Ann Oncol. 2004;15(10):1543-50.
37. Dalton LW, Pinder SE, Elston CE, Ellis IO, Page DL, Dupont WD, Blamey RW. Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement. Mod Pathol. 2000;13(7):730-5.
38. Jaganathan SK, Mandal M. Antiproliferative effects of honey and of its polyphenols: a review. J Biomed Biotechnol. 2009;2009:830616.
39. Sheikh N, Masood M, Naz N: Hematological and serological changes in the pre- and post-treatment breast cancer patients. HealthMED 2011, 5.
40. Al-Waili NS, Saloom KY, Al-Waili TN, Al-Waili AN, Akmal M, Al-Waili FS, Al-Waili HN. Influence of various diet regimens on deterioration of hepatic function and hematological parameters following carbon tetrachloride: a potential protective role of natural honey. Nat Prod Res. 2006;20(13):1258-64.
41. Fiorani M, Accorsi A, Blasa M, Diamantini G, Piatti E. Flavonoids from italian multifloral honeys reduce the extracellular ferricyanide in human red blood cells. J Agric Food Chem. 2006;54(21):8328-34.
42. Al-Waili NS. Effects of daily consumption of honey solution on hematological indices and blood levels of minerals and enzymes in normal individuals. J Med Food. 2003;6(2):135-40.
43. Aliyu M, Odunola OA, Owumi SE, Gbadegesin MA, Choudhary MI, Farooq AD, Rasheed H. Daily Consumption of Honey: Effects on Male Wister Albino Rats. Int J Food Nutr Safety. 2012;1(2):66-74.
44. Haakensen VD, Bjoro T, Luders T, Riis M, Bukholm IK, Kristensen VN, Troester MA, Homen MM, Ursin G, Borresen-Dale AL, et al. Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas. BMC Cancer. 2011;11:332.
45. Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res. 2000;2(5):335-44.
46. Medicine WUSo: Treatment with estrogen-lowering drugs shrinks tumors and reduces mastectomy rates in breast cancer patients. In.; 2011.
47. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med. 2002;346(5):340-52.
48. Lewis-Wambi JS, Jordan VC. Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Res. 2009;11(3):206.
49. Dauvois S, White R, Parker MG. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci. 1993;106(Pt 4):1377-88.
50. Tsiapara AV, Jaakkola M, Chinou I, Graikou K, Tolonen T, Virtanen V, Moutsatsou P. Bioactivity of Greek honey extracts on breast cancer (MCF-7), prostate cancer (PC-3) and endometrial cancer (Ishikawa) cells: Profile analysis of extracts. Food Chem. 2009;116(3):702-8.
51. Igney FH, Krammer PH. Death and anti-death: tumor resistance to apoptosis. Nat Rev Cancer. 2002;2(4):277-88.
52. Fernandez-Cabezudo MJ, El-Kharrag R, Torab F, Bashir G, George JA, El-Taji H, Al-Ramadi BK. Intravenous administration of manuka honey inhibits tumor growth and improves host survival when used in combination with chemotherapy in a melanoma mouse model. PLoS One. 2013;8(2):e55993.
53. Espana L, Fernandez Y, Rubio N, Torregrosa A, Blanco J, Sierra A. Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis. Breast Cancer Res Treat. 2004;87(1):33-44.
54. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 1997;91(5):627-37.